Wellington Management Group LLP reduced its stake in Novanta Inc. (NASDAQ:NOVT – Free Report) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 475,953 shares of the technology company’s stock after selling 17,531 shares during the period. Wellington Management Group LLP owned approximately 1.33% of Novanta worth $72,711,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Empowered Funds LLC purchased a new position in Novanta during the 4th quarter valued at about $26,000. SBI Securities Co. Ltd. bought a new stake in Novanta during the 4th quarter worth approximately $97,000. Venturi Wealth Management LLC lifted its stake in Novanta by 6,500.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock worth $111,000 after purchasing an additional 715 shares in the last quarter. Sanctuary Advisors LLC purchased a new stake in Novanta in the 3rd quarter worth approximately $232,000. Finally, HighTower Advisors LLC bought a new position in Novanta in the 3rd quarter valued at $257,000. 98.35% of the stock is currently owned by hedge funds and other institutional investors.
Novanta Stock Performance
Shares of NOVT opened at $104.12 on Friday. Novanta Inc. has a 12-month low of $103.71 and a 12-month high of $187.12. The company has a current ratio of 2.79, a quick ratio of 1.81 and a debt-to-equity ratio of 0.61. The company has a market cap of $3.74 billion, a PE ratio of 62.35 and a beta of 1.42. The stock has a 50-day moving average price of $139.98 and a 200-day moving average price of $156.97.
Wall Street Analyst Weigh In
Separately, Robert W. Baird lowered their price objective on Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research report on Monday, March 3rd.
Read Our Latest Analysis on NOVT
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Invest in Biotech Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.